At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
Green tea extract +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of a 12-week Administration of Green Tea Extract on Lipids in Patients With Type 2 Diabetes
Centro Universitario de Ciencias de la Salud, Mexico·interventional·Posted Aug 31, 2020·Updated Aug 31, 2020
In Brief
A clinical study evaluating Green tea extract and Placebo for Diabetes Mellitus, Type 2 and 2 related conditions. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The main objectives of this study were to evaluate the effect of a 12-week supplementation with GTE (400 mg every 12 hours) on serum lipids, arterial stiffness and inflammatory cytokines in patients with T2DM.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2, Dyslipidemias, Arterial Stiffness
CountriesMexico
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJun 2018
Primary CompletionJan 2019
First PostedAug 2020
TodayJul 2026
First PostedAug 31, 2020
Enrollment StartJun 12, 2018
Primary CompletionJan 14, 2019
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.8 years ago
Interventions
Green tea extractdietary
400 mg capsule
Placebodietary
400 mg capsule